Iradimed Corporation (NASDAQ:IRMD) Shares Bought by Shaker Investments LLC OH

Shaker Investments LLC OH lifted its holdings in Iradimed Corporation (NASDAQ:IRMD) by 0.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,894 shares of the medical equipment provider’s stock after buying an additional 233 shares during the period. Shaker Investments LLC OH owned approximately 0.24% of Iradimed worth $1,644,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently bought and sold shares of IRMD. Copeland Capital Management LLC lifted its stake in Iradimed by 12.6% in the 4th quarter. Copeland Capital Management LLC now owns 475,563 shares of the medical equipment provider’s stock worth $26,156,000 after purchasing an additional 53,138 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Iradimed by 189.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 66,632 shares of the medical equipment provider’s stock valued at $3,351,000 after buying an additional 43,635 shares in the last quarter. Oak Ridge Investments LLC acquired a new stake in shares of Iradimed in the 3rd quarter worth $2,188,000. Algert Global LLC raised its holdings in shares of Iradimed by 16.4% during the 3rd quarter. Algert Global LLC now owns 31,158 shares of the medical equipment provider’s stock worth $1,567,000 after acquiring an additional 4,384 shares during the period. Finally, JPMorgan Chase & Co. boosted its position in shares of Iradimed by 70.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 29,226 shares of the medical equipment provider’s stock valued at $1,470,000 after acquiring an additional 12,051 shares during the last quarter. 92.34% of the stock is currently owned by institutional investors and hedge funds.

Iradimed Stock Up 0.3 %

IRMD opened at $60.35 on Tuesday. The firm has a market cap of $764.63 million, a price-to-earnings ratio of 41.34 and a beta of 0.82. The business’s 50 day moving average is $56.77 and its two-hundred day moving average is $51.77. Iradimed Corporation has a 52 week low of $40.18 and a 52 week high of $63.29.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered Iradimed from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, February 5th.

Insider Buying and Selling at Iradimed

In other news, CFO John Glenn sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $54.18, for a total transaction of $135,450.00. Following the sale, the chief financial officer now owns 4,383 shares of the company’s stock, valued at $237,470.94. The trade was a 36.32 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 37.10% of the stock is owned by corporate insiders.

Iradimed Company Profile

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.